Lista de obras - Sergio Harari - Dominio Público Uruguay

A 69-year-old female with multiple, bilateral pulmonary nodules

artículo científico publicado en 2011

Absence of hyperhomocysteinemia in ten patients with primary pulmonary hypertension

artículo científico publicado en 1997

Adding new perspectives to the European Respiratory Review

artículo científico publicado en 2016

Airway inflammation in severe chronic obstructive pulmonary disease: relationship with lung function and radiologic emphysema

artículo científico publicado en 2002

An integrated approach in the diagnosis of smoking-related interstitial lung diseases

artículo científico publicado en 2012

Bosentan for patients with chronic thromboembolic pulmonary hypertension.

artículo científico publicado en 2008

Cellular interactions in the pathogenesis of interstitial lung diseases

artículo científico

Comorbidities in idiopathic pulmonary fibrosis: an underestimated issue

scientific article published on 01 September 2019

Current strategies in the treatment of invasive Aspergillus infections in immunocompromised patients.

artículo científico publicado en 1999

Data sharing: When better may be the enemy of good

artículo científico publicado en 2016

Diffuse cystic lung diseases: correlation between radiologic and functional status

artículo científico publicado en 2004

Does lobectomy for lung cancer in patients with chronic obstructive pulmonary disease affect lung function? A multicenter national study.

artículo científico publicado en 2005

Early consensus management for non-ICU ARF SARS-CoV-2 emergency in Italy: from ward to trenches

scientific article published on 07 April 2020

Effect of a gonadotrophin-releasing hormone analogue on lung function in lymphangioleiomyomatosis.

artículo científico publicado en 2007

Effects on health of air pollution: a narrative review

artículo científico

Efficacy of pirfenidone for idiopathic pulmonary fibrosis: An Italian real life study.

artículo científico publicado en 2015

Epidemiological studies in idiopathic pulmonary fibrosis: pitfalls in methodologies and data interpretation

artículo científico publicado en 2015

Epidemiology of Idiopathic Pulmonary Fibrosis in Northern Italy

artículo científico publicado en 2016

Estimates of the initial impact of the COVID-19 epidemic on overall mortality: evidence from Italy

artículo científico publicado en 2020

European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis

artículo científico publicado en 2010

Everolimus for the treatment of lymphangioleiomyomatosis: a phase II study

artículo científico publicado en 2015

Evolution of emphysema in relation to smoking.

artículo científico publicado en 2009

Fibrosing interstitial lung diseases: knowns and unknowns

scientific article published on 27 February 2019

Fibrotic interstitial lung diseases and air pollution: a systematic literature review

scientific article published on 18 August 2020

Formoterol mono- and combination therapy with tiotropium in patients with COPD: a 6-month study

artículo científico publicado en 2008

Future perspectives on rare pulmonary diseases and rare presentations of common disorders

artículo científico publicado en 2013

Hypocomplementemic urticarial vasculitis (HUVS) with precocious emphysema responsive to azathioprine

artículo científico publicado en 2013

IPF: New insight in diagnosis and prognosis

artículo científico publicado en 2010

IPF: new insight on pathogenesis and treatment

artículo científico publicado en 2010

Idiopathic pulmonary fibrosis

artículo científico publicado en 2005

Idiopathic pulmonary fibrosis and sleep disorders: no longer strangers in the night.

artículo científico

Idiopathic pulmonary fibrosis: from clinical trials to real-life experiences

artículo científico publicado en 2015

Lung Cryobiopsy for the Diagnosis of Interstitial Lung Diseases: A Series Contribution to a Debated Procedure

artículo científico publicado en 2019

Lung function predicts lung cancer risk in smokers: a tool for targeting screening programmes.

artículo científico publicado en 2009

Lymphangioleiomyomatosis: what do we know and what are we looking for? ⬇️

artículo científico publicado el 1 de marzo de 2011

Making the case for causality: what role do lung microbiota play in idiopathic pulmonary fibrosis?

scientific article published on 03 April 2020

Mild parenchymal lung disease is still lung disease

scientific article published on 26 November 2020

Non-invasive mechanical ventilation in patients with diffuse interstitial lung diseases

artículo científico publicado en 2014

Out with the old, in with the new for the European Respiratory Review

artículo científico publicado en 2017

Out-of-proportion pulmonary hypertension: a paradigm for rare diseases

artículo científico publicado en 2012

Pleural and pulmonary involvement in systemic lupus erythematosus

artículo científico publicado en 2010

Pulmonary Langerhans cell histiocytosis: a comprehensive analysis of 40 patients and literature review.

artículo científico

Pulmonary hypertension and chronic lung disease: where are we headed?

artículo científico publicado en 2019

Pulmonary hypertension associated with chronic obstructive lung disease and idiopathic pulmonary fibrosis

artículo científico publicado en 2014

Pulmonary hypertension in chronic interstitial lung diseases

artículo científico

Pulmonary hypertension in lymphangioleiomyomatosis: characteristics in 20 patients

artículo científico publicado en 2012

Pulmonary hypertension in patients with chronic myeloproliferative disorders

artículo científico publicado en 2015

Randomized phase II trial of inhaled budesonide versus placebo in high-risk individuals with CT screen-detected lung nodules

artículo científico publicado en 2010

Rare (pulmonary) disease day: "feeding the breath, energy for life!".

artículo científico publicado en 2015

Rare pulmonary disease and orphan drugs: a path to the future

scientific article published on 01 September 2019

Rare pulmonary diseases and orphan drugs: where do we stand and where are we going to?

artículo científico publicado en 2015

Rare pulmonary diseases: a path to the future

artículo científico publicado en 2010

Reversible airflow obstruction in lymphangioleiomyomatosis.

artículo científico publicado en 2009

Routine surgical videothoracoscopy as the first step of the planned resection for lung cancer

artículo científico publicado en 2009

Sirolimus Therapy for Patients With Lymphangioleiomyomatosis Leads to Loss of Chylous Ascites and Circulating LAM Cells.

artículo científico publicado en 2016

Smoking-related idiopathic interstitial pneumonia: A review

artículo científico

Suggestions for improving clinical utility of future guidelines for diagnosis and management of IPF - results of a Delphi survey

artículo científico publicado en 2021

The Health and Economic Burden of Air Pollution

artículo científico publicado en 2015

The International LAM Registry: a component of an innovative web-based clinician, researcher, and patient-driven rare disease research platform.

artículo científico

The changing face of a rare disease: lymphangioleiomyomatosis

artículo científico

The goal is to go further and do better: but how?

artículo científico publicado en 2016

The histology of pulmonary sarcoidosis: a review with particular emphasis on unusual and underrecognized features.

artículo científico publicado en 2009

The revolution of pulmonary arterial hypertension

artículo científico publicado en 2016

Thoracic involvement in generalised lymphatic anomaly (or lymphangiomatosis)

artículo científico publicado en 2016

Thoracic-abdominal MDCT: A one-stop-shop procedure for diagnosis of lymphangioleiomyomatosis

Ultra-rare cystic disease

scientific article published on 02 September 2020

Ultra-rare disease: an European perspective

artículo científico publicado en 2020

Understanding the priorities for women diagnosed with lymphangioleiomyomatosis: a patient perspective

artículo científico publicado en 2016

Update on diffuse parenchymal lung disease.

artículo científico publicado en 2010

Walking distance on 6-MWT is a prognostic factor in idiopathic pulmonary fibrosis

artículo científico publicado en 2008

Why we should care about ultra-rare disease

artículo científico publicado en 2016

Lista de obras de Sergio Harari

A 69-year-old female with multiple, bilateral pulmonary nodules

Absence of hyperhomocysteinemia in ten patients with primary pulmonary hypertension

Adding new perspectives to the European Respiratory Review

Airway inflammation in severe chronic obstructive pulmonary disease: relationship with lung function and radiologic emphysema

An integrated approach in the diagnosis of smoking-related interstitial lung diseases

Bosentan for patients with chronic thromboembolic pulmonary hypertension.

Cellular interactions in the pathogenesis of interstitial lung diseases

Comorbidities in idiopathic pulmonary fibrosis: an underestimated issue

Current strategies in the treatment of invasive Aspergillus infections in immunocompromised patients.

Data sharing: When better may be the enemy of good

Diffuse cystic lung diseases: correlation between radiologic and functional status

Does lobectomy for lung cancer in patients with chronic obstructive pulmonary disease affect lung function? A multicenter national study.

Early consensus management for non-ICU ARF SARS-CoV-2 emergency in Italy: from ward to trenches

Effect of a gonadotrophin-releasing hormone analogue on lung function in lymphangioleiomyomatosis.

Effects on health of air pollution: a narrative review

Efficacy of pirfenidone for idiopathic pulmonary fibrosis: An Italian real life study.

Epidemiological studies in idiopathic pulmonary fibrosis: pitfalls in methodologies and data interpretation

Epidemiology of Idiopathic Pulmonary Fibrosis in Northern Italy

Estimates of the initial impact of the COVID-19 epidemic on overall mortality: evidence from Italy

European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis

Everolimus for the treatment of lymphangioleiomyomatosis: a phase II study

Evolution of emphysema in relation to smoking.

Fibrosing interstitial lung diseases: knowns and unknowns

Fibrotic interstitial lung diseases and air pollution: a systematic literature review

Formoterol mono- and combination therapy with tiotropium in patients with COPD: a 6-month study

Future perspectives on rare pulmonary diseases and rare presentations of common disorders

Hypocomplementemic urticarial vasculitis (HUVS) with precocious emphysema responsive to azathioprine

IPF: New insight in diagnosis and prognosis

IPF: new insight on pathogenesis and treatment

Idiopathic pulmonary fibrosis

Idiopathic pulmonary fibrosis and sleep disorders: no longer strangers in the night.

Idiopathic pulmonary fibrosis: from clinical trials to real-life experiences

Lung Cryobiopsy for the Diagnosis of Interstitial Lung Diseases: A Series Contribution to a Debated Procedure

Lung function predicts lung cancer risk in smokers: a tool for targeting screening programmes.

Lymphangioleiomyomatosis: what do we know and what are we looking for? ⬇️

Making the case for causality: what role do lung microbiota play in idiopathic pulmonary fibrosis?

Mild parenchymal lung disease is still lung disease

Non-invasive mechanical ventilation in patients with diffuse interstitial lung diseases

Out with the old, in with the new for the European Respiratory Review

Out-of-proportion pulmonary hypertension: a paradigm for rare diseases

Pleural and pulmonary involvement in systemic lupus erythematosus

Pulmonary Langerhans cell histiocytosis: a comprehensive analysis of 40 patients and literature review.

Pulmonary hypertension and chronic lung disease: where are we headed?

Pulmonary hypertension associated with chronic obstructive lung disease and idiopathic pulmonary fibrosis

Pulmonary hypertension in chronic interstitial lung diseases

Pulmonary hypertension in lymphangioleiomyomatosis: characteristics in 20 patients

Pulmonary hypertension in patients with chronic myeloproliferative disorders

Randomized phase II trial of inhaled budesonide versus placebo in high-risk individuals with CT screen-detected lung nodules

Rare (pulmonary) disease day: "feeding the breath, energy for life!".

Rare pulmonary disease and orphan drugs: a path to the future

Rare pulmonary diseases and orphan drugs: where do we stand and where are we going to?

Rare pulmonary diseases: a path to the future

Reversible airflow obstruction in lymphangioleiomyomatosis.

Routine surgical videothoracoscopy as the first step of the planned resection for lung cancer

Sirolimus Therapy for Patients With Lymphangioleiomyomatosis Leads to Loss of Chylous Ascites and Circulating LAM Cells.

Smoking-related idiopathic interstitial pneumonia: A review

Suggestions for improving clinical utility of future guidelines for diagnosis and management of IPF - results of a Delphi survey

The Health and Economic Burden of Air Pollution

The International LAM Registry: a component of an innovative web-based clinician, researcher, and patient-driven rare disease research platform.

The changing face of a rare disease: lymphangioleiomyomatosis

The goal is to go further and do better: but how?

The histology of pulmonary sarcoidosis: a review with particular emphasis on unusual and underrecognized features.

The revolution of pulmonary arterial hypertension

Thoracic involvement in generalised lymphatic anomaly (or lymphangiomatosis)

Thoracic-abdominal MDCT: A one-stop-shop procedure for diagnosis of lymphangioleiomyomatosis

Ultra-rare cystic disease

Ultra-rare disease: an European perspective

Understanding the priorities for women diagnosed with lymphangioleiomyomatosis: a patient perspective

Update on diffuse parenchymal lung disease.

Walking distance on 6-MWT is a prognostic factor in idiopathic pulmonary fibrosis

Why we should care about ultra-rare disease